Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?

C. Hengstenberg*, J. Erdmann, P. Charron

*Corresponding author for this work
3 Citations (Scopus)
Original languageEnglish
JournalCardiovascular Research
Issue number2
Pages (from-to)298-301
Number of pages4
Publication statusPublished - 01.02.2003

Research Areas and Centers

  • Research Area: Medical Genetics

Cite this